CLEANING VALIDATION FOR ESTIMATION OF ACTIVE INGREDIENTS' RESIDUES OF VICAZID UNCOATED TABLETS (PYRANTEL 100 MG/MEBENDAZOLE 150 MG) ON SURFACES OF PHARMACEUTICAL MANUFACTURING EQUIPMENT USING SWAB SAMPLING AND HPLC METHOD
Keywords:Residual estimation, Swab sampling, Cleaning validation, HPLC
Objective: The validation of HPLC methods for residual estimation of pyrantel and mebendazole in swab samples from equipment surfaces after manufacturing of Vicazid uncoated tablets and the demonstration of the efficiency of the cleaning procedure.
Methods: For pyrantel residues: Column-Luna Silica 250Ã—4.6 mm, 5 Âµm; Mobile phase-a mixture of acetonitrile, acetic acid, diethyl amine and water (92.8:3:1.2:3); The flow rate-1.0 ml/min; The detector wavelength-288 nm; The injection volume-20 Î¼l. For mebendazole residues: Column-Luna C18(2) 150Ã—4.6 mm, 5 Âµm; Mobile phase-a mixture of methanol and 0.05 M monobasic potassium phosphate solution (60:40) pH 5.5; The flow rate-1.5 ml/min; The detector wavelength-247 nm; The injection volume-15 Î¼l.
Results: The calibration curve is linear (the correlation coefficient>0.999) over a concentration range 0.04-80Î¼g/ml (pyrantel pamoate) and 0.005-50Î¼g/ml (mebendazole); The limit of detection and limit of quantitation-0.04 (pyrantel pamoate)/0.005 (mebendazole) and 0.08 (pyrantel pamoate)/0.0125Î¼g/ml (mebendazole), respectively; The mean recovery is>90 %; No interference from swab solution was observed and samples were stable for 24Â h. The determined amounts (varying 0.02â€“9.74 Âµg pyrantel residues and 0.09â€“61.19 Âµg mebendazole) are well below the calculated limit of contamination.
Conclusion: The HPLC methods with appropriate swab wipe procedure were validated and the obtained results confirm that the cleaning procedures used are able to remove residues of both active ingredients from equipment surfaces.
EU Guidelines for good manufacturing practice for medicinal products for human and veterinary use, Eudra Lex-Vol. 4. Annex 15: Qualification and Validation, Brussels; 2014.
Guide to inspections validation of cleaning processes, US. Food and Drug Administration, Office of Regulatory Affairs, Washington, DC; 1993.
Guidance on aspects of cleaning validation in active pharmaceutical ingredient plants, Active Pharmaceutical Committee (APIC); 1999.
LeBlance DA. Establishing scientifically justified acceptance criteria for cleaning validation of finished drug products. Pharm Technol 1998;22:136â€“48.
Fourman GL, Mullen MV. Determining cleaning validation acceptance limits for Pharmaceutical manufacturing operations. Pharm Technol 1993;17:54-60.
Klinkenberg R, Streel B, Ceccato A. Development and validation of a liquid chromatographic method for the determination of the amlodipine residues on manufacturing equipment surfaces. J Pharm Biomed Anal 2003;32:345â€“52.
Dubey N, Mandhanya M, Jain DK. Cleaning level acceptance criteria and HPLC-DAD method validation for the determination of Nabumetone residues on manufacturing equipment using swab sampling. J Pharm Anal 2012;2:478â€“83.
U. S. Pharmacopeia national formulary USP 37 NF 32. Mebendazole 2014;3:3657-8.
U. S. Pharmacopeia national formulary USP 37 NF 32. Mebendazole 2014;3:3658-9.
U. S. Pharmacopeia national formulary USP 37 NF 32. Pyrantel pamoate; 2014;3:4491-2.
ICH Harmonized tripartite guideline, Validation of analytical procedures, text and methodology Q2 (R1); 2005.
ErmerJ, Miller JH. Method validation in pharmaceutical analysis. Weinheim: WILEY-VCH Verlag GmbH & Co. KGa A; 2005.
Eurachem Guide. 2nd ed. The fitness forpurpose of analytical methodsâ€“A laboratory guide to method validation and related topics; 2014.
Kumar VS, Sanjeev T. Overview of cleaning validation in pharmaceutical manufacturing unit. IJPSR 2012;1:154-64.
McCormick PY, Cullen LF. Cleaning validation. In: Berry IR, Nash RA, editors. 2nd ed. New York: Marcel Dekker; 1993. p. 319-49.
Chudzik GM. General guide to recovery studies using swab sampling methods for cleaning validation. J Validation Technol 1998;5:77â€“81.
Schifflet MJ, Shapiro M. Development of analytical methods to accurately and precisely determine residual active pharmaceutical ingredients and cleaning agents on pharmaceutical surfaces. Am Pharm Rev Winter 2002;4:35â€“9.
Boca B, Apostolides Z, Pretorius E. A validated HPLC method for determining residues of a dual active ingredient anti-malarial drug on manufacturing equipment surfaces. J Pharm Biomed Anal 2005;37:461â€“8.
Kumar N, Sangeetha D, Balakrishna P. Development and validation of a UPLC method for the determination of duloxetine hydrochloride residues on pharmaceutical manufacturing equipment surfaces. Pharm Methods 2011;2:161â€“6.
Forsyth RJ, Haynes DV. Cleaning validation in pharmaceutical research facility. Pharm Technol 1998;22:104â€“12.
Sajid SS, Arayne MS, Sultana N. Validation of cleaning of pharmaceutical manufacturing equipment, illustrated by determination of cephradine residues. Anal Methods 2010;2:397-401.